Table II.

Effects of in vivo administration of anti-VCAM-1 Aba

Treatment TypeTotal Cellsb% of Cells in Phenotype
CD48CD4+8+Mature
Anti-VCAM-1110 ± 275 ± 388 ± 96 ± 4
IgG control146 ± 376 ± 186 ± 28 ± 2
  • a Mean ± SD for three to six experiments.

  • b Total of ×10−6 per lobe of the thymus.